INSP
insider transactionsInspire Medical Systems, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-4.0K
0 buy · 4.0K sell
Net value · 90d
-$175.9K
$0 in · $175.9K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
3
0 buy · 4.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Title: Chief Product and Inno…
$114.3K
2.6K sh · $43.28
Own -9%
-
Sell·S
Title: Chief Product and Inno…
$30.1K
700 sh · $43.01
Own -2%
-
Sell·S
Director · 10b5-1
$31.5K
696 sh · $45.31
Own -2%
-
Other·F
Director
$2.8K
50 sh · $56.70
Own -1%
-
Grant·A
Director
$0
3.6K sh
Own +16%
-
Grant·A
Director
$0
3.6K sh
Own +16%
-
Grant·A
Director · 10b5-1
$0
3.6K sh
Own +14%
-
Grant·A
Director
$0
3.6K sh
Own +80%
-
Grant·A
Director
$0
3.6K sh
Own +106%
-
Grant·A
Director
$0
3.6K sh
Own +134%
-
Grant·A
Director
$16.0K
307 sh · $52.07
Own +7%
-
Grant·A
Director
$16.0K
308 sh · $52.07
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | John Rondoni | Sell S | 2.6K | $114.3K |
| May 14, 2026 | John Rondoni | Sell S | 700 | $30.1K |
| May 8, 2026 | Shawn Mccormick 10b5-1 | Sell S | 696 | $31.5K |
| May 1, 2026 | Georgia Melenikiotou | Other F | 50 | $2.8K |
| Apr 30, 2026 | Dana G Mead Jr. | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Casey M Tansey | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Shawn Mccormick 10b5-1 | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Georgia Melenikiotou | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Curet Myriam | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Cynthia Burks | Grant A | 3.6K | $0 |
| Apr 15, 2026 | Georgia Melenikiotou | Grant A | 307 | $16.0K |
| Apr 15, 2026 | Casey M Tansey | Grant A | 308 | $16.0K |
About INSP insider trading
This page tracks insider transactions for Inspire Medical Systems, Inc. (INSP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.